Medicofarma Biotech SA (WSE:MDB)

Market Cap	21.01M
Revenue (ttm)	279.31K
Net Income (ttm)	-3.21M
Shares Out	67.98M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,084
Average Volume	12,925
Open	0.3100
Previous Close	0.3100
Day's Range	0.2850 - 0.3100
52-Week Range	0.2310 - 0.5900
Beta	3.24
RSI	55.15
Earnings Date	Aug 7, 2025

About Medicofarma Biotech

Medicofarma Biotech SA, a biotechnology company, provides medicines, medicinal products, and biotechnology products. The company is involved in the research and development works in collaboration with pharmaceutical and cosmetic manufacturing plants, as well as research units. It also offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics; and covid-19 test kits, such as real time PCR genetic tests. The company was formerly known as Inbook Spólka Akcyjna. Medicofarma Biotech SA...

• Industry: Biotechnology & Medical Research
• Sector: Healthcare
• Founded: 2001
• Employees: 20
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MDB

Financial Performance

In 2024, Medicofarma Biotech's revenue was 1.22 million, an increase of 63.14% compared to the previous year's 750,809. Losses were -2.30 million, -33.11% less than in 2023.